News
Oral Presentations: The final oral presentation schedule will be available on the website by Friday, July 25, 2025. Scheduling will occur in 15-minute increments, grouped with presentations from the ...
Protagonist Therapeutics, Inc.Protagonist and Takeda Announce ASCO Plenary Presentation Highlighting Full 32-Week Results from Phase 3 VERIFY Study of Rusfertide, Showing Reductions in Phlebotomy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback